Clinical trial
Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
NCT00001213 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00001213 |
|---|---|
| Title | Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis |
| Official title | Trial of Topical Cysteamine in the Treatment of Corneal Cystine Crystal Accumulation in Cystinosis |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystinosis |
| Intervention type | Drug |
| Interventions | Cysteamine |
| Enrollment | 328 |
| Start date | Apr 1, 1986 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: